GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XTER:EVT) » Definitions » E10

Evotec SE (XTER:EVT) E10 : €0.15 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Evotec SE E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.15 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Evotec SE's average E10 Growth Rate was -11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Evotec SE was 84.20% per year. The lowest was 12.30% per year. And the median was 48.25% per year.

As of today (2024-05-27), Evotec SE's current stock price is €9.18. Evotec SE's E10 for the quarter that ended in Mar. 2024 was €0.15. Evotec SE's Shiller PE Ratio of today is 61.20.

During the past 13 years, the highest Shiller PE Ratio of Evotec SE was 592.25. The lowest was 58.97. And the median was 155.52.


Evotec SE E10 Historical Data

The historical data trend for Evotec SE's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE E10 Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 - 0.25 0.17 0.15

Evotec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.16 0.14 0.15 0.15

Competitive Comparison of Evotec SE's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's Shiller PE Ratio falls into.



Evotec SE E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.12/125.0381*125.0381
=-0.120

Current CPI (Mar. 2024) = 125.0381.

Evotec SE Quarterly Data

per share eps CPI Adj_EPS
201406 -0.003 99.543 -0.004
201409 -0.030 99.823 -0.038
201412 0.010 99.543 0.013
201503 -0.010 99.717 -0.013
201506 0.110 100.417 0.137
201509 -0.020 100.417 -0.025
201512 0.040 99.717 0.050
201603 -0.010 100.017 -0.013
201606 0.030 100.717 0.037
201609 0.070 101.017 0.087
201612 0.110 101.217 0.136
201703 0.050 101.417 0.062
201706 0.020 102.117 0.024
201709 0.020 102.717 0.024
201712 0.070 102.617 0.085
201803 0.020 102.917 0.024
201806 0.100 104.017 0.120
201809 0.230 104.718 0.275
201812 0.210 104.217 0.252
201903 0.090 104.217 0.108
201906 -0.020 105.718 -0.024
201909 0.130 106.018 0.153
201912 0.050 105.818 0.059
202003 0.110 105.718 0.130
202006 -0.070 106.618 -0.082
202009 -0.010 105.818 -0.012
202012 0.000 105.518 0.000
202103 0.320 107.518 0.372
202106 0.370 108.486 0.426
202109 0.820 109.435 0.937
202112 -0.200 110.384 -0.227
202203 -0.410 113.968 -0.450
202206 -0.160 115.760 -0.173
202209 -0.270 118.818 -0.284
202212 -0.150 119.345 -0.157
202303 -0.080 122.402 -0.082
202306 -0.080 123.140 -0.081
202309 -0.220 124.195 -0.221
202312 -0.090 123.773 -0.091
202403 -0.120 125.038 -0.120

Add all the adjusted EPS together and divide 10 will get our e10.


Evotec SE  (XTER:EVT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Evotec SE's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=9.18/0.15
=61.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Evotec SE was 592.25. The lowest was 58.97. And the median was 155.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Evotec SE E10 Related Terms

Thank you for viewing the detailed overview of Evotec SE's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (XTER:EVT) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.
Executives
Dr. Werner Lanthaler Board of Directors

Evotec SE (XTER:EVT) Headlines